Home » Newsletters » BioWorld

BioWorld

Aug. 9, 2001

View Archived Issues

Appointments And Advancements

United Therapeutics, Actelion Prepare to Present Cases To FDA

Erythropoietin Goes From Kidney Source To Added Site In Brain As Hypoxia-Curbing Neuroprotectant

Chimeric Closes First Part Of Financing, Brings In About $10M

4M Vysis Shares For Sale; Stockholder Offering Most

Pfizer Deal Terms Change, Onyx Tumbles 21 Percent

Other News To Note